UK-based diagnostics maker Virax Biolabs files for US IPO
By Val Kennedy, UK-based diagnostics marketer Virax Biolabs (VRAX) has filed to hold a US initial public offering. The company didn’t specify the size and pricing of the proposed IPO. It hopes to list its shares on Nasdaq under the symbol VRAX. Boustead Securities is serving as lead bookrunner, according to its filing. Virax is[…]